Economic Issues in Health Care
BE 608
Homework Assignment
Homework assignment available on Canvas
- Relates to topics we're discussing today
- Due next week, 11/4, by 11:59pm (upload to Canvas)
Grading Information
Elective course curve
- Excellent: 35% Max
- Good: 40% Max
- Pass: Max 35%
- Low Pass or Fail: 5%
Typically 75% of students get Exc or Good, 25% get pass, and 1 or 2 get LP or F.
I don't know how this translates to grades across other groups on campus (SPH, Medical School, Ford, etc). Check with your program!
Group Project
Last week, several of you brought up challenges with the payment system when we talked about costs.
- Paying per procedure vs. paying for "quality"
- Paying more for care patients get after things get bad (like surgeries) and less for "preventive" care
The question is: what can we do about it?
Group Project
For the group project, you will research one of the attempts to improve this situation. I've tried to select programs that have been in place long enough that there has been some rigorous research on their success or failure. Sign up for your groups on Canvas (at least 5 in group, no more than 7). There will be two groups for each program.
- Blue Cross Blue Shield of Massachusetts Alternative Quality Contract
- CalPERS Reference Pricing
- Medicare Hospital Readmission Program
- Bundled Payments for Care Improvement
- Medicare Shared Savings Program
State Question
Has your chosen state done anything to reduce health care costs? Have these measure been successful?
Spending as % of GDP in the US and OECD countries (source: OECD health Statistics)
Spending by Payer
•What explains the significant role that government plays in every health care system (including the US)?
•How should we think about efficiency in health care?
To answer both, we need to understand how health care is different from other goods.
Two Related Questions
Outline
•Economic Concepts of Efficiency
•How is Health Care Different?
•Applying Economic Concepts of Efficiency to Health Care
•Equity and the Distribution of Health Resources
Economic Concepts of Efficiency
•The fact that the US spends more than other countries and does not have better health outcomes to show for it, is often interpreted as evidence that the US system is inefficient.
•What exactly does this mean?
Is the US Healthcare System Uniquely Inefficient?
Two Economic Concepts of Efficiency
Productive Efficiency
- Are we producing goods in the most efficient manner?
- Are we getting the greatest possible health improvement from the amount that we are spending? (Could we spend less and get the same benefit?)
- (e.g.) Are invasive procedures the most efficient way to reduce mortality from coronary disease?
Two Economic Concepts of Efficiency
Allocative Efficiency
- Is the market producing the “right” mix of goods?
- Does the last dollar spent on health provide the same benefit as the last dollar spent on other goods or services?
- How does the cost of reducing disease compare to the value of other consumption foregone?
Economic Concepts of Efficiency
It is hard to measure these two concepts of efficiency directly.
However, economic theory tells us that if certain conditions are met, a free market will produce an efficient outcome. They are:
- Homogeneous product
- Large number of price-taking sellers
- Ease of entry and exit
- Buyers and sellers have good (and symmetric) information
- No externalities in production or consumption
When 1+ condition is violated, we say there is market failure, which means that government intervention may improve efficiency.
Economic Concepts of Efficiency
“I will hold that virtually all the special features of this industry, in fact, stem from the prevalence of uncertainty (p. 946)” - Kenneth Arrow
Economic Concepts of Efficiency
Demand for medical care subject to uncertainty about:
Future health and need for care
Demand for insurance
Appropriate treatment and the likelihood of success
Reliance on physician expertise
Asymmetric Information
Adverse Selection,
Moral Hazard
The insurance company lacks info the consumer has
The consumer lacks information the physician has
Principal-Agent Problem
Adverse Selection
Imagine there are two groups of people: the sick and the healthy.
Sick have a 5% chance of a $100,000 health bill.
The healthy have a 1% chance of a $100,000 health bill.
What is expected value of each groups's health expenses?
If both groups are risk-neutral, how much would they be willing to pay for insurance?
Adverse Selection
Imagine there are two groups of people: the sick and the healthy.
Sick have a 5% chance of a $100,000 health bill.
The healthy have a 1% chance of a $100,000 health bill.
Say the insurance company starts out with 50% sick and 50% healthy.
What are their expected costs per person?
In order to break even "on average", what is the minimum premium they can charge?
Adverse Selection
Imagine there are two groups of people: the sick and the healthy.
Sick have a 5% chance of a $100,000 health bill.
The healthy have a 1% chance of a $100,000 health bill.
If they charge a premium of $3000, how many sick people sign up and how many healthy people sign up?
Given this, what is the insurance company's true expected cost?
Adverse Selection
Taking it one step further... suppose WITHIN the group of sick people, half are "very sick" and half are "slightly sick."
The very sick have an 8% chance of a $100,000 health bill.
The slightly sick have a 2% chance of a $100,000 health bill.
Currently the premium is at $5000 (the average among the sick).
Who among the sick is interested in buying health insurance?
Adverse Selection
Now assume within the "very sick" there are two groups: the "extremely super sick" and the merely "very sick".... etc.
As premium rises, the relatively healthy want to leave. This makes the premium rise more and the pool of the existing insured get more expensive. Which in turn causes more relatively healthy people to leave...
Eventually, only the most sick remain in the insurance pool, and premiums are very very high.
Health economists call this a "Death Spiral".
State question: What is your state doing to prevent a death spiral in their insurance market?
Moral Hazard
Imagine you break your arm and the doctor offers you a choice of a super fancy decorated cast or a regular cast. The super fancy decorated cast costs $1000 more, but you'd only be willing to pay $100 more for the fancy decorations.
Vs
What would you choose if you're paying out of pocket? What about if insurance covers it?
Moral Hazard (aside)
What do you choose if you're paying for it? What about if you're forcing your students to pay for it?
Vs
$239.00
$0
Moral Hazard
Moral hazard can create economic inefficiency if insurance results in individuals consuming health care that they place a low value on when they gain insurance.
From an economic perspective, this happens when the marginal cost of providing the care exceeds the individual's willingness to pay.
In an ideal world, insurance companies would know what you truly value and only cover those services--but insurance companies don't have this knowledge--this is why moral hazard is an asymmetric information problem.
Oregon Health Insurance Experiment
Interesting study that can help us learn about moral hazard--
Oregon Health Insurance Experiment
- Oregon Medicaid program had about 10,000 spots open for low income adults, but many more than 10,000 people wanted health insurance and were qualified.
- Their solution? Made the spots available through a lottery.
- One of the few truly "randomized" experiments in health economics--some people were randomly assigned to receive health insurance versus a control group.
What happened to the people who were "randomly assigned" eligibility for Medicaid?
Oregon Health Insurance Experiment
Finkelstein et al 2012 Quarterly Journal of Economics
Oregon Health Insurance Experiment
Finkelstein et al 2012 Quarterly Journal of Economics
Oregon Health Insurance Experiment
Finkelstein et al 2012 Quarterly Journal of Economics
OHIE
Caveats: Can't say for sure it's low value--but it's suggestive;
results may be different in other states (Massachusetts reform), or maybe over longer term
OHIE
Some of the most dramatic effects were about financial outcomes
Applying Efficiency Concepts
•Garber and Skinner use the concept of a production function to illustrate how economic concepts of efficiency can be applied to health care.
•Production function comes from the theory of the firm.
~Shows how inputs can be optimally combined to produce different levels of output.
~The frontier represents the best we can do given current technology.
•Two concepts of efficiency
~Productive efficiency: are we on the frontier?
~Allocative efficiency: what is the “best” point on the frontier?
Applying Efficiency Concepts
Production Frontier represents the greatest possible amount of health produced by a given quantity of inputs.
(No guarantee of being on frontier.)
[board work]
Welfare is Maximized when MB = MC
•Economic welfare is the difference between total benefits and total cost; This will be maximized when the slopes of the TB and TC curves are equal
Welfare Maximization
•Consider a particular medical treatment or intervention. For simplicity, assume that the cost is the same for all patients treated.
•The benefit of the treatment will vary across patients. Imagine that we can order patients in terms of this benefit. Start by providing the treatment to the patient receiving the greatest benefit.
•An efficient allocation is where the benefit received by the “marginal” patient equals the cost of the treatment.
~Arrow: “Under ideal insurance, medical care will always be taken in any case in which the expected utility, taking account of the probabilities, exceeds the expected medical cost. (p. 965)
Key economic concept: Thinking on the margin.
Where is welfare/value maximized?
What is the total social benefit from health care in this situation?
What if we continue consuming until N1 or beyond?
Many non-US countries attempt to control over-treatment by limiting quantity. Under what circumstances would this lead to a "better" outcome? A "worse" outcome?
Many non-US countries attempt to control over-treatment by limiting quantity. Under what circumstances would this lead to a "better" outcome? A "worse" outcome?
From an economic point of view, "optimal" consumption means saying no to beneficial care when the cost is too high.
One of the many reasons people don't like economists...
•With insurance, patients pay a fraction of the true cost (plus implicit costs associated with discomfort, side effects, etc).
Where would a patient with partial insurance consume? Full insurance?
Revisiting Moral Hazard
Revisiting Moral Hazard
Revisiting Moral Hazard
Copays can reduce some of the welfare loss from moral hazard
A Typology of Medical Interventions
Interventions or technologies can be distinguished by the shape and location of their marginal benefit and marginal cost curves.
- Type I: Highly Cost-Effective (“Home Run”) Interventions
- Type II: Potentially Cost-Effective with Heterogeneous Benefits
- Type III: Interventions with Modest or Uncertain Effectiveness
Type 1A: Low Cost, Highly Effective for Many Patients
Examples
- Antibiotics introduced in the 20th century
- Aspirin, beta blockers after AMI
- The Surgeon General’s Report on Smoking
- Vaccines
- Probably statins
Since costs are low, widespread diffusion does not lead to high spending. In fact, by preventing more serious illness, they may be cost-saving.
Type 1A: Low Cost, Highly Effective for Many Patients
Huge gains to society
Type 1B: Highly Effective Technologies
Because appropriate patients are clearly defined, the cost of over-treatment is low.
Type 1B: Highly Effective Technologies
Type 1B (aside)
Many economists believe the next set of challenges the health system will face is--what do you do when technologies are both HIGHLY effective and EXTREMELY expensive?
E.g. gene therapy
What happened when such medical care was developed previously?
Type 2: Benefits for some, costs for many
Examples
- C- Sections
- Advanced Imaging
- Cardiac Interventions
Type 2: Benefits for some, costs for many
Type 2: Benefits for some, costs for many
Type 2: Benefits for some, costs for many
"After orthopedists began billing for MRI, the number of MRI procedures used within thirty days of a first visit increased by about 38 percent." -Baker, Health Affairs 2010
•When evidence on outcomes is limited and physician beliefs vary, the benefit of treatment may be small or even negative.
Examples
- Arthroscopic surgery for osteoarthritis
- Proton beam treatment for prostate cancer
- ICU days for chronically ill
- Aggressive treatment for end-stage lung cancer
- HDC/Bone marrow transplant for stage 4 breast cancer
Type III Interventions
Long term care hospitals versus skilled nursing facilities. (A study by Einav, Finkelstein and Mahoney)
Type III Interventions
What happens when a new LTCH opens in a community
Long term care hospitals versus skilled nursing facilities. (A study by Einav, Finkelstein and Mahoney)
Type III Interventions
What happens when a new LTCH opens in a community
Long term care hospitals versus skilled nursing facilities. (A study by Einav, Finkelstein and Mahoney)
Type III Interventions
Our results imply that Medicare could save about $4.6 billion per year by not allowing for discharge to LTCHs
Long term care hospitals versus skilled nursing facilities. (A study by Einav, Finkelstein and Mahoney)
Type III Interventions
Would patients be harmed?
Long term care hospitals versus skilled nursing facilities. (A study by Einav, Finkelstein and Mahoney)
Type III Interventions
Would patients be harmed?
This is just one example--some researchers estimate that as much as 30 percent of medical spending in the US is for low value care (e.g., McGinnis et al 2013).
- But--hard to know that an intervention is low value. It goes back to information asymmetries.
Type III Interventions
Public policies are often assessed using a method called "marginal value of public funds." This takes the beneficiaries' benefit from the policy ("willingness to pay," measured in dollars) as a ratio of the (net) costs to the government.
Public Policies
Public Policies
Hendren and Sprung-Keyser QJE 2020
Public Policies
Hendren and Sprung-Keyser QJE 2020
https://www.policyinsights.org/
Marginal Value of Public Funds
Typically MVPF is higher for health programs aimed at children
- Longer period over which children can potentially accrue benefits
- Highly sensitive period, small investments can yield big outputs
MVPF calculations are useful for thinking about government budgets, but not all of society wants to "think like an economist."
- If the program increases earnings, thus increasing taxes paid, it will have a very high MVPF.
- But as a society we might want to take care of those who can't earn (e.g. due to disability)--these programs can still be valuable even if the government does not recoup its "investment."
Factors Contributing to Inefficient Health Spending
•The majority of health spending is financed by insurance.
Consumers do not bear the full cost of the care they receive.
•The demand for care is strongly influenced by physicians.
Fee-for-service reimbursement creates an incentive for more spending, even if marginal benefit is low.
•Physicians have imperfect information on the benefits of interventions.
There are large variations in the way existing technology is used.
The US is uniquely prone to high spending
Supply side factors
The US is uniquely prone to high spending
Demand side factors
The Cost Control Challenge
•To achieve value for money, health systems must find a way to encourage the adoption and diffusion of Type I technologies, discourage the use of Type III interventions and target the use of Type II technologies to the right patients.
•Other countries often rely on expert panels to make evidence-based recommendations on the comparative effectiveness and cost implications of medical treatments.
•In the US system it is often private firms (insurers, employers) that are left to make resource allocation decisions.
Equity and the Distribution of Health Resources
How should we think about health care?
Is it a "right" or a "good"?
Should we finance it with social insurance or private insurance?
From the National Academy of Social Insurance:
Life is filled with risks. Uncertainty is the rule because nobody can predict with confidence his or her future state of wealth or health… Certain risks we have agreed to confront as a society, rather than as individuals. Citizens have decided, through the political system, that we need financial protection against some of life's difficulties that are hard to face as individuals. These include old age, ill health, unemployment, disability that makes it impossible to work, injury on the job, and the death of a family breadwinner. For all these conditions, we rely on help from social insurance programs, which are financed by workers and employers.
How should we think about health care?
In other countries, health care is financed mainly through social insurance.
~Example: France’s Social Security system has 4 branches
–Health
–Work accidents and illness
–Old age, retirement
–Family (children’s allowances, disability, housing)
~Private insurance represents complementary (gap) coverage
•In the US, Medicare is a social insurance program; Medicaid is not
Efficiency and Distributional Consequences of Medicare
When Medicare was established in 1965, only about 25 percent of the elderly had private health insurance.
Low coverage rate can be explained by market failure (adverse selection) and the fact that many elderly could not afford insurance.
Medicare established universal coverage for Americans age 65 and up.
Enrollee premiums, which do not vary by health status, cover only a fraction of total spending. Thus, Medicare represents redistribution
- From young to old
- From healthy to sick
- From higher to lower incomes
Equity and the Financing of Care for the Non-Elderly
•The Affordable Care Act was designed to address some remaining market failures in health insurance.
•But, fundamentally, the ACA is about redistribution.
•To what extent should public policy enforce transfers
~From young to old?
~From healthy to sick?
~From higher to lower incomes?
For Next Class:
What is your state doing (if anything) to prevent a health insurance
market death spiral? What is your state doing to alleviate moral hazard or adverse selection (e.g. in their Medicaid program)?
We will discuss the Affordable Care Act/Obamacare and the future of health care reform.
Please read the two assigned readings.
Copy of Lecture 2
By umich
Copy of Lecture 2
- 386